EMEA (Europe, Middle East and Africa) Active Transdermal Drug Delivery Device Market Report 2018

March 2018 | 116 pages | ID: E7E814221D9EN
QYResearch

Abstracts

In this report, the EMEA Active Transdermal Drug Delivery Device market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Active Transdermal Drug Delivery Device for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Active Transdermal Drug Delivery Device market competition by top manufacturers/players, with Active Transdermal Drug Delivery Device sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Noven Pharmaceuticals, Inc.
• Transdermal Corp.
• Johnson & Johnson (Janssen Pharmaceuticals Inc.)
• Mylan N.V.
• 3M
• Actavis, Inc.
• Bayer AG
• Boehringer Ingelheim GmbH
• Corium International, Inc.
• Echo Therapeutics, Inc.
• GlaxoSmithKline plc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Patches
• Gels

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Home Use

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Active Transdermal Drug Delivery Device Market Report 2018

1 ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE OVERVIEW

1.1 Product Overview and Scope of Active Transdermal Drug Delivery Device
1.2 Classification of Active Transdermal Drug Delivery Device
  1.2.1 EMEA Active Transdermal Drug Delivery Device Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Active Transdermal Drug Delivery Device Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Patches
  1.2.4 Gels
1.3 EMEA Active Transdermal Drug Delivery Device Market by Application/End Users
  1.3.1 EMEA Active Transdermal Drug Delivery Device Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Home Use
1.4 EMEA Active Transdermal Drug Delivery Device Market by Region
  1.4.1 EMEA Active Transdermal Drug Delivery Device Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Active Transdermal Drug Delivery Device (2013-2025)
  1.5.1 EMEA Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Active Transdermal Drug Delivery Device Revenue and Growth Rate (2013-2025)

2 EMEA ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Active Transdermal Drug Delivery Device Market Competition by Players/Manufacturers
  2.1.1 EMEA Active Transdermal Drug Delivery Device Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Active Transdermal Drug Delivery Device Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Active Transdermal Drug Delivery Device Sale Price by Players (2013-2018)
2.2 EMEA Active Transdermal Drug Delivery Device (Volume and Value) by Type/Product Category
  2.2.1 EMEA Active Transdermal Drug Delivery Device Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Active Transdermal Drug Delivery Device Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Active Transdermal Drug Delivery Device Sale Price by Type (2013-2018)
2.3 EMEA Active Transdermal Drug Delivery Device (Volume) by Application
2.4 EMEA Active Transdermal Drug Delivery Device (Volume and Value) by Region
  2.4.1 EMEA Active Transdermal Drug Delivery Device Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Active Transdermal Drug Delivery Device Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Active Transdermal Drug Delivery Device Sales Price by Region (2013-2018)

3 EUROPE ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Active Transdermal Drug Delivery Device Sales and Value (2013-2018)
  3.1.1 Europe Active Transdermal Drug Delivery Device Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Active Transdermal Drug Delivery Device Revenue and Growth Rate (2013-2018)
3.2 Europe Active Transdermal Drug Delivery Device Sales and Market Share by Type
3.3 Europe Active Transdermal Drug Delivery Device Sales and Market Share by Application
3.4 Europe Active Transdermal Drug Delivery Device Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Active Transdermal Drug Delivery Device Sales Volume by Countries (2013-2018)
  3.4.2 Europe Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018)
  3.4.3 Germany Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  3.4.4 France Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  3.4.5 UK Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  3.4.6 Russia Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  3.4.7 Italy Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)

4 MIDDLE EAST ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Active Transdermal Drug Delivery Device Sales and Value (2013-2018)
  4.1.1 Middle East Active Transdermal Drug Delivery Device Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Active Transdermal Drug Delivery Device Revenue and Growth Rate (2013-2018)
4.2 Middle East Active Transdermal Drug Delivery Device Sales and Market Share by Type
4.3 Middle East Active Transdermal Drug Delivery Device Sales and Market Share by Application
4.4 Middle East Active Transdermal Drug Delivery Device Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Active Transdermal Drug Delivery Device Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  4.4.4 Israel Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  4.4.5 UAE Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  4.4.6 Iran Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)

5 AFRICA ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Active Transdermal Drug Delivery Device Sales and Value (2013-2018)
  5.1.1 Africa Active Transdermal Drug Delivery Device Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Active Transdermal Drug Delivery Device Revenue and Growth Rate (2013-2018)
5.2 Africa Active Transdermal Drug Delivery Device Sales and Market Share by Type
5.3 Africa Active Transdermal Drug Delivery Device Sales and Market Share by Application
5.4 Africa Active Transdermal Drug Delivery Device Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Active Transdermal Drug Delivery Device Sales Volume by Countries (2013-2018)
  5.4.2 Africa Active Transdermal Drug Delivery Device Revenue by Countries (2013-2018)
  5.4.3 South Africa Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Active Transdermal Drug Delivery Device Sales and Growth Rate (2013-2018)

6 EMEA ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Noven Pharmaceuticals, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Transdermal Corp.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Mylan N.V.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 3M
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Actavis, Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bayer AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim GmbH
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Corium International, Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Active Transdermal Drug Delivery Device Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Echo Therapeutics, Inc.
6.12 GlaxoSmithKline plc

7 ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE MANUFACTURING COST ANALYSIS

7.1 Active Transdermal Drug Delivery Device Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Transdermal Drug Delivery Device

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Transdermal Drug Delivery Device Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Transdermal Drug Delivery Device Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ACTIVE TRANSDERMAL DRUG DELIVERY DEVICE MARKET FORECAST (2018-2025)

11.1 EMEA Active Transdermal Drug Delivery Device Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Active Transdermal Drug Delivery Device Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Active Transdermal Drug Delivery Device Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Active Transdermal Drug Delivery Device Price and Trend Forecast (2018-2025)
11.2 EMEA Active Transdermal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Active Transdermal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Active Transdermal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Active Transdermal Drug Delivery Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Active Transdermal Drug Delivery Device Sales Forecast by Type (2018-2025)
11.7 EMEA Active Transdermal Drug Delivery Device Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Active Transdermal Drug Delivery Device
Figure EMEA Active Transdermal Drug Delivery Device Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Active Transdermal Drug Delivery Device Sales Volume Market Share by Type (Product Category) in 2017
Figure Patches Product Picture
Figure Gels Product Picture
Figure EMEA Active Transdermal Drug Delivery Device Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Active Transdermal Drug Delivery Device by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure EMEA Active Transdermal Drug Delivery Device Market Size (Million USD) by Region (2013-2025)
Figure Europe Active Transdermal Drug Delivery Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Active Transdermal Drug Delivery Device Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Active Transdermal Drug Delivery Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Active Transdermal Drug Delivery Device Revenue (Million USD) Status and Forecast by Countries
Figure Africa Active Transdermal Drug Delivery Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Active Transdermal Drug Delivery Device Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Active Transdermal Drug Delivery Device Sales Volume and Growth Rate (2013-2025)
Figure EMEA Active Transdermal Drug Delivery Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Active Transdermal Drug Delivery Device Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales Share by Players (2013-2018)
Figure 2017 Active Transdermal Drug Delivery Device Sales Share by Players
Figure 2017 Active Transdermal Drug Delivery Device Sales Share by Players
Figure EMEA Active Transdermal Drug Delivery Device Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Revenue (Million USD) by Players (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Revenue Share by Players (2013-2018)
Table 2017 EMEA Active Transdermal Drug Delivery Device Revenue Share by Players
Table 2017 EMEA Active Transdermal Drug Delivery Device Revenue Share by Players
Table EMEA Active Transdermal Drug Delivery Device Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales Share by Type (2013-2018)
Figure Sales Market Share of Active Transdermal Drug Delivery Device by Type (2013-2018)
Figure EMEA Active Transdermal Drug Delivery Device Sales Market Share by Type (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Active Transdermal Drug Delivery Device by Type in 2017
Table EMEA Active Transdermal Drug Delivery Device Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales Share by Application (2013-2018)
Figure Sales Market Share of Active Transdermal Drug Delivery Device by Application (2013-2018)
Figure EMEA Active Transdermal Drug Delivery Device Sales Market Share by Application in 2017
Table EMEA Active Transdermal Drug Delivery Device Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Sales Share by Region (2013-2018)
Figure Sales Market Share of Active Transdermal Drug Delivery Device by Region (2013-2018)
Figure EMEA Active Transdermal Drug Delivery Device Sales Market Share in 2017
Table EMEA Active Transdermal Drug Delivery Device Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Active Transdermal Drug Delivery Device Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Active Transdermal Drug Delivery Device by Region (2013-2018)
Figure EMEA Active Transdermal Drug Delivery Device Revenue Market Share Regions in 2017
Table EMEA Active Transdermal Drug Delivery Device Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Revenue and Growth Rate (2013-2018)
Table Europe Active Transdermal Drug Delivery Device Sales (K Units) by Type (2013-2018)
Table Europe Active Transdermal Drug Delivery Device Market Share by Type (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Market Share by Type in 2017
Table Europe Active Transdermal Drug Delivery Device Sales (K Units) by Application (2013-2018)
Table Europe Active Transdermal Drug Delivery Device Market Share by Application (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Market Share by Application in 2017
Table Europe Active Transdermal Drug Delivery Device Sales (K Units) by Countries (2013-2018)
Table Europe Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Sales Market Share by Countries in 2017
Table Europe Active Transdermal Drug Delivery Device Revenue (Million USD) by Countries (2013-2018)
Table Europe Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018)
Figure Europe Active Transdermal Drug Delivery Device Revenue Market Share by Countries in 2017
Figure Germany Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure France Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure UK Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Active Transdermal Drug Delivery Device Sales (K Units) by Type (2013-2018)
Table Middle East Active Transdermal Drug Delivery Device Market Share by Type (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Market Share by Type (2013-2018)
Table Middle East Active Transdermal Drug Delivery Device Sales (K Units) by Applications (2013-2018)
Table Middle East Active Transdermal Drug Delivery Device Market Share by Applications (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Sales Market Share by Application in 2017
Table Middle East Active Transdermal Drug Delivery Device Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Active Transdermal Drug Delivery Device Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Sales Volume Market Share by Countries in 2017
Table Middle East Active Transdermal Drug Delivery Device Revenue (Million USD) by Countries (2013-2018)
Table Middle East Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018)
Figure Middle East Active Transdermal Drug Delivery Device Revenue Market Share by Countries in 2017
Figure Saudi Arabia Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Active Transdermal Drug Delivery Device Sales (K Units) by Type (2013-2018)
Table Africa Active Transdermal Drug Delivery Device Sales Market Share by Type (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Sales Market Share by Type (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Sales Market Share by Type in 2017
Table Africa Active Transdermal Drug Delivery Device Sales (K Units) by Application (2013-2018)
Table Africa Active Transdermal Drug Delivery Device Sales Market Share by Application (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Sales Market Share by Application (2013-2018)
Table Africa Active Transdermal Drug Delivery Device Sales Volume (K Units) by Countries (2013-2018)
Table Africa Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Sales Market Share by Countries (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Sales Market Share by Countries in 2017
Table Africa Active Transdermal Drug Delivery Device Revenue (Million USD) by Countries (2013-2018)
Table Africa Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Revenue Market Share by Countries (2013-2018)
Figure Africa Active Transdermal Drug Delivery Device Revenue Market Share by Countries in 2017
Figure South Africa Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Table Novartis AG Active Transdermal Drug Delivery Device Basic Information List
Table Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis AG Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Novartis AG Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Basic Information List
Table Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Transdermal Corp. Active Transdermal Drug Delivery Device Basic Information List
Table Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Transdermal Corp. Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Transdermal Corp. Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Basic Information List
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Mylan N.V. Active Transdermal Drug Delivery Device Basic Information List
Table Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Mylan N.V. Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Mylan N.V. Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table 3M Active Transdermal Drug Delivery Device Basic Information List
Table 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure 3M Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure 3M Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Actavis, Inc. Active Transdermal Drug Delivery Device Basic Information List
Table Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Actavis, Inc. Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Actavis, Inc. Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Bayer AG Active Transdermal Drug Delivery Device Basic Information List
Table Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer AG Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Bayer AG Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Basic Information List
Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Corium International, Inc. Active Transdermal Drug Delivery Device Basic Information List
Table Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate (2013-2018)
Figure Corium International, Inc. Active Transdermal Drug Delivery Device Sales Market Share in EMEA (2013-2018)
Figure Corium International, Inc. Active Transdermal Drug Delivery Device Revenue Market Share in EMEA (2013-2018)
Table Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Basic Information List
Table GlaxoSmithKline plc Active Transdermal Drug Delivery Device Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Transdermal Drug Delivery Device
Figure Manufacturing Process Analysis of Active Transdermal Drug Delivery Device
Figure Active Transdermal Drug Delivery Device Industrial Chain Analysis
Table Raw Materials Sources of Active Transdermal Drug Delivery Device Major Manufacturers in 2017
Table Major Buyers of Active Transdermal Drug Delivery Device
Table Distributors/Traders List
Figure EMEA Active Transdermal Drug Delivery Device Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Active Transdermal Drug Delivery Device Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Active Transdermal Drug Delivery Device Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Active Transdermal Drug Delivery Device Sales Market Share Forecast by Region (2018-2025)
Table EMEA Active Transdermal Drug Delivery Device Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Region (2018-2025)
Table Europe Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Active Transdermal Drug Delivery Device Sales Market Share Forecast by Countries (2018-2025)
Table Europe Active Transdermal Drug Delivery Device Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Active Transdermal Drug Delivery Device Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Active Transdermal Drug Delivery Device Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Active Transdermal Drug Delivery Device Sales Market Share Forecast by Countries (2018-2025)
Table Africa Active Transdermal Drug Delivery Device Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Active Transdermal Drug Delivery Device Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Active Transdermal Drug Delivery Device Sales Market Share Forecast by Type (2018-2025)
Table EMEA Active Transdermal Drug Delivery Device Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Active Transdermal Drug Delivery Device Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources